News

Court reprimands Valeant and Pershing Square

A California court says that Allergan raises serious questions as to whether Valeant and Pershing Square engaged in insider trading.

Read More

Sales growth and new appointments at Luxottica

Luxottica reported sales of CA$8.2 billion for the first nine months of 2014, a 2.1% increase over the same period last year.

Read More

Fear of vision loss

People fear blindness as much as they do cancer, Alzheimer’s disease and HIV/AIDS, according to a poll by Research!America and Alliance for Eye and Vision Research.

Read More

Excellent third quarter for Valeant

Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in 1960.

Read More

Tough quarter for Johnson & Johnson in the eye care market

Despite a good quarter for the company in general (sales of US$18.5 billion, up by 5.1% over last year), Johnson & Johnson reported a drop in eye care product sales in the third quarter of 2014.

Read More

Valeant increases offer for Allergan

Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion.

Read More

A strong quarter for Essilor

Essilor’s revenue rose to CA$1.59 million in the third quarter of 2014, a 14.5% increase over the same period last year.

Read More

FLEYE wins Good Design Award 2014

The Danish company FLEYE wins the Good Design Award 2014, the most prestigious award for design in Japan.

Read More

EyeCheck shortlisted for prestigious James Dyson award

EyeCheck, a start-up founded by University of Waterloo students, made the final list of 20 entries for the James Dyson Award.

Read More

A first in Canada: two patients receive the Argus II implant

Two patients at the Toronto Western Hospital have become the first in Canada to receive the Argus II Retinal Prosthesis Device.

Read More